ASSEMBLY BIOSCIENCES, INC. - ASMB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 7.8% | 1,553,748 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 7.8% | 1,553,748 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 7.8% | 1,553,748 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 6.9% | 1,362,882 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP Ltd. | 6.9% | 1,359,514 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Management, L.L.C. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Kim, David T. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Saito Edric C. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Short Daniel S. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Warren, John R. | 8.1% | 1,604,590 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 8.1% | 1,604,590 | View |
| May 27, 2026 | SCHEDULE 13D/A | — | 25.1% | 4,977,089 | View |
| May 11, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 5.4% | 865,251 | View |
| May 11, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 5.4% | 865,251 | View |
| May 11, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 5.4% | 865,251 | View |
| May 11, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 4.8% | 758,963 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.